Engeneic

Index
Globenewswire

EnGeneIC Honored with 2026 Breakthrough in Glioblastoma Biotech Award at Northwell Foundation Lenox Hill Neurosurgery Brain Cancer Gala in New York

Globenewswire

EnGeneIC Announces First Patient Dosed in Recurrent Glioblastoma Clinical Trial

Globenewswire

EnGeneIC Launches Groundbreaking New Australian Trial for Innovative Cancer Therapy, with International Trial Site in Singapore to Follow

Globenewswire

Distinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer Therapeutics